S-1/A - CG Oncology, Inc. (0001991792) (Filer)

1 min to read

S-1/A – CG Oncology, Inc. (0001991792) (Filer)

Filed: 2024-01-18 AccNo: 0001193125-24-009621 Size: 6 MB
Source: S-1/A – CG Oncology, Inc. (0001991792) (Filer)

SPAC Risk Update with Doug Ellenoff: What to Expect in 2025

The second half of 2024 saw a significant uptick in SPAC activity both on the IPO and deal side. With...
Beta Bionics Files Registration Statement for Proposed Initial Public Offering

Beta Bionics, Inc., a leader in the development of advanced diabetes management solutions, announced that it has filed a Form...
EXCLUSIVE: AI-Powered Software Company Quadrupling HQ Space In Addison

Amid a major Dallas-Fort Worth data center boom, the town of Addison is helping a homegrown company that relies on AI for...
Glass Lewis and ISS Publish 2025 Updates

On November 14, 2024, Glass Lewis published its 2025 U.S. Benchmark Policy Guidelines (U.S. Guidelines), and its 2025 Shareholder Proposals & ESG-Related Benchmark...
Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq

Hong Kong, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (the “Company”), a Hong Kong-based interior design...